BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20044992)

  • 1. Overcoming remyelination failure in multiple sclerosis and other myelin disorders.
    Fancy SP; Kotter MR; Harrington EP; Huang JK; Zhao C; Rowitch DH; Franklin RJ
    Exp Neurol; 2010 Sep; 225(1):18-23. PubMed ID: 20044992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why does remyelination fail in multiple sclerosis?
    Franklin RJ
    Nat Rev Neurosci; 2002 Sep; 3(9):705-14. PubMed ID: 12209119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
    Motavaf M; Sadeghizadeh M; Javan M
    Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo.
    Butt AM; Dinsdale J
    Exp Neurol; 2005 Mar; 192(1):125-33. PubMed ID: 15698626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
    Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
    Stoffels JM; de Jonge JC; Stancic M; Nomden A; van Strien ME; Ma D; Sisková Z; Maier O; Ffrench-Constant C; Franklin RJ; Hoekstra D; Zhao C; Baron W
    Brain; 2013 Jan; 136(Pt 1):116-31. PubMed ID: 23365094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin regulatory factor drives remyelination in multiple sclerosis.
    Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
    Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical remyelination: a new target for repair therapies in multiple sclerosis.
    Chang A; Staugaitis SM; Dutta R; Batt CE; Easley KE; Chomyk AM; Yong VW; Fox RJ; Kidd GJ; Trapp BD
    Ann Neurol; 2012 Dec; 72(6):918-26. PubMed ID: 23076662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remyelination in multiple sclerosis.
    Chari DM
    Int Rev Neurobiol; 2007; 79():589-620. PubMed ID: 17531860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis - remyelination failure as a cause of disease progression.
    Hagemeier K; Brück W; Kuhlmann T
    Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N; Chesik D; Hoekstra D; De Keyser J
    Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling in remyelination in multiple sclerosis: friend or foe?
    Xie C; Li Z; Zhang GX; Guan Y
    Mol Neurobiol; 2014 Jun; 49(3):1117-25. PubMed ID: 24243343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.
    Coman I; Aigrot MS; Seilhean D; Reynolds R; Girault JA; Zalc B; Lubetzki C
    Brain; 2006 Dec; 129(Pt 12):3186-95. PubMed ID: 16766541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biology of CNS remyelination: the key to therapeutic advances.
    Franklin RJ; Kotter MR
    J Neurol; 2008 Mar; 255 Suppl 1():19-25. PubMed ID: 18317673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.